On Invalid Date, Trxade Health (NASDAQ: MEDS) reported Q1 2023 earnings per share (EPS) of -$0.07, up 41.67% year over year. Total Trxade Health earnings for the quarter were -$677.95 thousand. In the same quarter last year, Trxade Health's earnings per share (EPS) was -$0.12.
As of Q2 2023, Trxade Health's earnings has grown year over year. Trxade Health's earnings in the past year totalled -$3.19 million.
What is MEDS's earnings date?
Trxade Health's earnings date is Invalid Date. Add MEDS to your watchlist to be reminded of MEDS's next earnings announcement.
What was MEDS's revenue last quarter?
On Invalid Date, Trxade Health (NASDAQ: MEDS) reported Q1 2023 revenue of $2.25 million up 30.63% year over year. In the same quarter last year, Trxade Health's revenue was $3.24 million.
What was MEDS's revenue growth in the past year?
As of Q2 2023, Trxade Health's revenue has grown 3.76% year over year. This is 5.4 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of -1.64%. Trxade Health's revenue in the past year totalled $10.46 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.